Moreover, rostafuroxin‐sensitive hypertension they develop (Figure 8) is also completely normalized by the administration of losartan (Pereira‐Acácio et al., 2022), an antagonist of type 1 angiotensin II receptors (Timmermans et al., 1995), suggesting an interaction between rostafuroxin and RAAS. Here, AGTR1 is linked to hypertensive disorder.